[New York, New York April 9, 2024] – Today, Ovarian Cancer Research Alliance (OCRA) proudly unveiled its latest innovation in supporting individuals affected by ovarian cancer: the “Find a Doctor” tool. This free function, accessible through the OCRA website, is designed to connect patients and their families with qualified healthcare professionals specializing in ovarian and … Continued
Ovarian Cancer Research Alliance congratulates Frieda Weeks, a founding member of Hope for Heather and an OCRA Advocate Leader, on winning NewsChannel 9 WSYR’s Remarkable Women of Central New York contest. Frieda was recognized for her steadfast dedication to increasing ovarian cancer awareness and raising funds for research focused on this disease. In an interview … Continued
Tiffany Mecham, an OCRA Advocate Leader, is using her platform as a contestant in the upcoming Mrs. Idaho pageant to raise awareness of ovarian cancer. In a segment with Sophia Doumani for KBOI CBS 2 Boise News, Tiffany talks about what motivates her to use her platform to accelerate progress against ovarian cancer. As an … Continued
OCRA’s Advocates Push for Critical Legislative Action at Spring Advocacy Day More than 140 advocates, representing 37 states and 107 congressional districts, met virtually with nearly 180 congressional offices last week to request increased federal funding around vital ovarian and related gynecologic cancer programs. Chad Ramsey, OCRA’s Vice President of Policy, takes you behind the … Continued
It was a busy and exciting month for OCRA’s policy team and advocates from all across the country. OCRA’s 2024 Spring Advocacy Day took place on March 20, during which 140 advocates met with their Members of Congress and urged them to support increased funding for education and research programs focused on ovarian and related … Continued
OCRA’s four Collaborative Research Development Grants, including a partnership grant through Microsoft AI for Health, are multi-investigator studies set to tackle the most pressing issues in research, treatment and care. “In an all-around stellar crop of new OCRA-funded research for 2024, our collaborative studies hold particular promise,” says Audra Moran, OCRA’s President & CEO. “By … Continued
Chef Elle Simone Scott, dedicated board member of Ovarian Cancer Research Alliance (OCRA) and renowned figure in the culinary world through America’s Test Kitchen and more, is raising crucial awareness about ovarian cancer, as shared in a San Francisco Bay Times article “Coming Out for Women’s Health”. Diagnosed with ovarian cancer in 2016, Elle is … Continued
OCRA Harnessing Artificial Intelligence to Develop Blood Test to Detect Ovarian Cancer In a news segment for NBC 4 New York, Dr. Daniel Heller, an OCRA grantee, discussed the exciting OCRA-funded study being undertaken in partnership with Microsoft AI for Health. “We’re really excited about the power of AI because there has been so much success in … Continued
Get inspired by these OCRA Heroes who have tapped into live music’s incredible power to bring people together and transformed it into support for Ovarian Cancer Research Alliance (OCRA). They have organized multiple benefit concerts, which provide a meaningful avenue to honor the memory of their loved ones who passed away from ovarian cancer. Event … Continued
OCRA’s Advocates are off to a running start this year with help from our largest Advocate Leader cohort in program history, at 125 participants representing 39 states and 111 congressional districts. Together with the OCRA policy team, Advocate Leaders are working to advance crucial legislative goals, including expanding federal funding of ovarian and other gynecologic cancer … Continued
Research breakthroughs are around the corner. In 2023, OCRA announced $9.2 million in research initiatives for 2024 — the largest in our history — including awarding 20 grants to scientists at 15 prestigious institutions. Recommended for funding by OCRA’s Scientific Advisory Committee from a competitive evaluation process, these exceptional researchers and their forward-thinking studies will tackle … Continued
An OCRA research team is using Artificial Intelligence (AI) to develop a blood test to potentially detect ovarian cancer, as part of an OCRA-funded study in partnership with Microsoft AI for Good Lab. OCRA grantee Daniel Heller, PhD, lead researcher at The Daniel Heller Lab at Memorial Sloan Kettering Cancer Center discusses this cutting-edge technology … Continued
Get email updates about research news, action alerts, and ways to join the fight.
